Clinical Trials Browser

Phase 1 × INDUSTRY × vandetanib × Clear all

NCT01539655 2017-05-02

Vandetanib

Phase 1 Completed

Carcinoma, Medullary

NCT00503711 2016-08-31

Phase I Chinese PK

Phase 1 Completed

Neoplasms

NCT00450138 2016-08-29

Open Label, Phase I ZD6474 Head and Neck Cancer Study

Phase 1 Completed

Carcinoma, Squamous Cell, Head and Neck Neoplasms

NCT00681798 2016-08-29

Dose Escalation Study With Zactima and Chemotherapy in Metastatic Pancreas Carcinoma

Phase 1 Completed

Gastrointestinal

Pancreatic Neoplasms

NCT00807170 2016-08-29

Investigate the Maximum Tolerated Dose of Vandetanib and Concurrent Whole Brain Radiotherapy (WBRT) in Patients With Non-small Cell Lung Cancer (NSCLC) and Brain Metastases

Phase 1 Terminated

Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis

NCT00496275 2016-08-26

Phase I Combination With Vinorelbine or Gemcitabine Plus Cisplatin in Locally Advanced or Metastatic NSCLC

Phase 1 Completed

Carcinoma, Non-Small-Cell Lung

NCT00499850 2016-08-25

Phase I FOLFOX Combination

Phase 1 Completed

Adenocarcinoma

NCT00506051 2016-08-25

ZD6474(Vandetanib) + Alimta Combo Study

Phase 1 Completed

Carcinoma, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00507091 2016-08-25

Phase I Irinotecan, 5-Fluorouracil and Leucovorin Combination

Phase 1 Completed

Adenocarcinoma, Neoplasm Metastasis